Business Description
Acrux Ltd
ISIN : AU000000ACR3
Compare
Compare
Traded in other countries / regions
ACR.AustraliaFJY.GermanyARUXF.USA IPO Date
2010-09-24Description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.02 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -1.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -8.37 | |||||
| Beneish M-Score | -1.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 60.6 | |||||
| 3-Year EBITDA Growth Rate | 47.2 | |||||
| 3-Year EPS without NRI Growth Rate | 67.3 | |||||
| 3-Year Book Growth Rate | -26.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -13.07 | |||||
| 12-1 Month Momentum % | -29.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.04 | |||||
| Days Sales Outstanding | 67.49 | |||||
| Days Payable | 159.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.6 | |||||
| Shareholder Yield % | -1.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.03 | |||||
| Operating Margin % | -23.72 | |||||
| Net Margin % | -6.21 | |||||
| FCF Margin % | 3.63 | |||||
| ROE % | -10.47 | |||||
| ROA % | -5.96 | |||||
| ROIC % | 3907.68 | |||||
| ROC (Joel Greenblatt) % | -174.71 | |||||
| ROCE % | -30.89 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 10.99 | |||||
| PS Ratio | 1.64 | |||||
| PB Ratio | 3.37 | |||||
| Price-to-Tangible-Book | 3.06 | |||||
| Price-to-Free-Cash-Flow | 32 | |||||
| Price-to-Operating-Cash-Flow | 32 | |||||
| EV-to-EBIT | -6.02 | |||||
| EV-to-EBITDA | -7.56 | |||||
| EV-to-Revenue | 1.43 | |||||
| EV-to-FCF | 39.85 | |||||
| Price-to-Median-PS-Value | 0.2 | |||||
| Earnings Yield (Greenblatt) % | -16.61 | |||||
| FCF Yield % | 2.2 | |||||
| Forward Rate of Return (Yacktman) % | 132.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARUXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acrux Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.654 | ||
| EPS (TTM) ($) | -0.001 | ||
| Beta | -0.04 | ||
| Volatility % | 21.82 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0306 | ||
| 12-1 Month Momentum % | -29.33 | ||
| 52-Week Range ($) | 0.0306 - 0.0433 | ||
| Shares Outstanding (Mil) | 290.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acrux Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acrux Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acrux Ltd Frequently Asked Questions
What is Acrux Ltd(ARUXF)'s stock price today?
The current price of ARUXF is $0.03. The 52 week high of ARUXF is $0.04 and 52 week low is $0.03.
When is next earnings date of Acrux Ltd(ARUXF)?
The next earnings date of Acrux Ltd(ARUXF) is .
Does Acrux Ltd(ARUXF) pay dividends? If so, how much?
Acrux Ltd(ARUXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers